Mulligan Richard 4
4 · Sana Biotechnology, Inc. · Filed Sep 26, 2024
Insider Transaction Report
Form 4
Mulligan Richard
Director
Transactions
- Sale
Common Stock
2024-09-24$4.08/sh−150,000$612,570→ 2,848,121 total - Sale
Common Stock
2024-09-25$3.89/sh−150,000$583,170→ 2,698,121 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.16, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $4.13, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.